ENTITY
Everest Medicines

Everest Medicines (1952 HK)

101
Analysis
Health CareChina
Everest Medicines Limited operates as a late clinical-stage biopharmaceutical company. The Company engages in licensing, clinical development, and commercialization of therapies for oncology, immunology, cardio-renal disease, and infectious disease. Everest Medicines markets its products in China and other emerging Asia Pacific markets.
more
Refresh
27 Sep 2020 02:40

Everest Medicines IPO Initiation: Potent Medicine

Everest Medicines Everest Medicines (EVEREST HK) is a biopharmaceutical company which targets four therapeutic areas - oncology, immunology,...

Logo
403 Views
Share
24 Sep 2020 14:56

Everest Medicines (云顶新耀) Pre-IPO: Thoughts on Valuation

Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and...

Logo
587 Views
Share
20 Sep 2020 09:56

ECM Weekly (20 September 2020) - Ant Group, Ming Yuan Cloud, Neusoft Edu, Computer Age Mgt

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...

Share
06 Aug 2020 11:45

Everest Medicines (云顶新耀) Pre-IPO: License-In Specialist Led by Biotech Investors

Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and...

Logo
560 Views
Share
x